B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis

Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line

(2013) Ling Wang et al.   Cancer Cell International

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence

(2012) Tai-Wei Sun et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma

(2012) Nourredine Himoudi et al.   Clinical & Translational Oncology

Potential of human γδ T cells for immunotherapy of osteosarcoma

(2012) Zhaoxu Li   MOLECULAR BIOLOGY REPORTS

New targets and approaches in osteosarcoma

(2012) Jonathan Gill et al.   PHARMACOLOGY & THERAPEUTICS

B7-H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells

(2011) Takaaki Arigami et al.   CANCER SCIENCE

Palliative therapy for osteosarcoma

(2011) Costantino Errani et al.   Expert Review of Anticancer Therapy

Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis

(2011) Andreas Brunner et al.   GYNECOLOGIC ONCOLOGY

B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes

(2011) Christina Tekle et al.   INTERNATIONAL JOURNAL OF CANCER

Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3

(2011) Thomas Schneider et al.   Journal of Thoracic Oncology

Osteosarcoma

(2010) J. Ritter et al.   ANNALS OF ONCOLOGY

B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis

(2010) Takaaki Arigami et al.   ANNALS OF SURGERY

Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma

(2010) Jing Sun et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Enhancement of effector CD8+T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites

(2010) Hiroko Kobori et al.   IMMUNOLOGY

Decreased Ratio of CD8+ T Cells to Regulatory T Cells Associated with Decreased Survival in Dogs with Osteosarcoma

(2010) B.J. Biller et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma

(2010) S. J. Strauss et al.   ONCOLOGIST

Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma

(2010) Jarkko T. Korpi et al.   SURGICAL ONCOLOGY-OXFORD

T Cell Activation

(2009) Jennifer E. Smith-Garvin et al.   Annual Review of Immunology

Clinical importance of B7-H3 expression in human pancreatic cancer

(2009) I Yamato et al.   BRITISH JOURNAL OF CANCER

Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases

(2009) G. Chavin et al.   CLINICAL CANCER RESEARCH

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

(2009) Cameron S. Brandt et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression

(2009) Nabil Ahmed et al.   MOLECULAR THERAPY

Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion

(2008) Olivia Fromigué et al.   JOURNAL OF BIOLOGICAL CHEMISTRY